Paul Rothman insider trades

Open-market stock purchases and sales by Paul Rothman, Director at Merck & Co, Inc, from SEC Form 4 filings since May 22, 2014.

Recent trades

DateStockTradeValue
May 29, 2026MRK Merck & Co, IncBought (not open market)$220K
Feb 11, 2026LH Labcorp Holdings IncBought (not open market)—
Feb 10, 2026LH Labcorp Holdings IncBought (not open market)—

Companies traded

  • MRK Merck & Co, Inc: other filings, last May 29, 2026
  • LH Labcorp Holdings Inc: other filings, last Feb 11, 2026
  • CGIX Cancer Genetics, Inc: other filings, last May 22, 2014

Get free alerts when Paul Rothman files a new trade →